Fig. 2From: Risk and characteristics of tuberculosis after anti-tumor necrosis factor therapy for inflammatory bowel disease: a hospital-based cohort study from KoreaIncidence rates (per 100,000 person-years) of active tuberculosis infection according to age: all patients (circle), latent tuberculosis-negative group (triangle), infliximab group (square). *Linearity p < 0.05. TNF, tumor necrosis factor; TB, tuberculosis; LTBI, latent tuberculosis infectionBack to article page